secwatch.observer — SEC 8-K summary
======================================

Issuer:     DermTech, Inc. (—)
CIK:        0001651944
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001651944-24-000005
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.05, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DermTech cuts 15% of workforce (~30 employees); COO departs; targets $40M savings
--------------------------------------------------------------------------------

- Workforce reduction of ~30 employees (~15% of total) approved by Board on Jan 29, 2024.
- Combined with June 2023 plan, expects ~$40M total operating expense reductions vs FY2022.
- One-time pre-tax charge of ~$1.3M in Q1 2024 for severance and related costs.
- COO Claudia Ibarra's last day is Feb 2, 2024; separation agreement terms pending.
- Company focuses resources on growing reimbursed DMT billable samples and payer coverage.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651944/000165194424000005/0001651944-24-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651944/000165194424000005/dmtk-20240129.htm
  HTML page:      https://secwatch.observer/filing/0001651944-24-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer